Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Allied Minds subsidiary Spin Transfer Technologies announces the appointment of John Kispert as Chairman of the Board of Directors

Allied Minds
Posted on: 24 Sep 18

Boston, MA (24 September 2018) - Allied Minds subsidiary Spin Transfer Technologies (STT) today announces the appointment of John Kispert as the independent Chairman of its Board of Directors.

 

“John has a stellar global reputation built on a demonstrable track record of success in driving commercial traction, licensing IP, and ultimately in creating and crystallizing value for shareholders,” commented Jill Smith, CEO of Allied Minds. “The STT management team is fortunate to have access to John’s guidance, counsel and network at this critical juncture in the commercialization of its MRAM enabling technologies.”

 

Kispert has held a number of executive and board positions during his more than 20 years in the memory and semiconductor industries. He was CEO of Spansion, Inc., where he guided the company through a period of significant sales growth and margin expansion, including the acquisition of a division of Fujitsu Microelectronics, to its eventual sale to Cypress Semiconductor in March 2015. Before that, Kispert spent 13 years at KLA-Tencor, including as president, COO and CFO, and helped transform the semiconductor equipment company from $300 million to over $3 billion in annual revenues. Preceding his time at KLA-Tencor, Kispert held several management positions at IBM.

 

Kispert also served as an active board member at a series of highly successful technology companies through their acquisitions or IPOs.  These include Gigamon, Inc., a provider of network traffic visibility solutions, TriNet, a cloud-based professional employer organization for small and medium-sized businesses and Barracuda Networks, a security and storage solutions provider.

 

“I am delighted to join the board of Spin Transfer Technologies — where I see an exciting opportunity to drive commercialization and licensing of its key MRAM-enabling technologies,” said Kispert. “I look forward to applying my knowledge and network for the benefit of the company and its shareholders, and to unlocking the widespread adoption of this faster, lower-power, next-generation memory for consumers and enterprises.”

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 24/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.